Beneficios de la metabolómica no dirigida en el campo de la Nutrición

  1. Tania Portolés 1
  2. Leticia Lacalle Bergeron 1
  3. David Izquierdo Sandoval 1
  4. Juan Vicente Sancho 1
  5. Alfredo Fernández Quintela 2
  6. María Puy Portillo 2
  1. 1 Enviromental and Public Health Analytical Chemistry, Research Institute for Pesticides and Water (IUPA), Universitat Jaume I, Castellón de la Plana, Spain
  2. 2 Nutrition and Obesity group, Department of Nutrition and Food Science, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), Lucio Lascaray Research Centre, Vitoria, Spain
Aldizkaria:
Revista española de nutrición humana y dietética

ISSN: 2173-1292

Argitalpen urtea: 2021

Zenbakien izenburua: IV Congreso de Alimentación, Nutrición y Dietética. Nutrición personalizada y dietética de precisión

Alea: 25

Zenbakia: 3

Orrialdeak: 22-23

Mota: Artikulua

Beste argitalpen batzuk: Revista española de nutrición humana y dietética

Erreferentzia bibliografikoak

  • (1) Lindon JC, Holmes E, Nicholson JK. Peer Reviewed: So What’s the Deal with Metabonomics? Anal Chem. 2003; 75(17): 384-91.
  • (2) Lacalle-Bergeron L, Izquierdo-Sandoval D, Sancho JV, López FJ, Hernández F, Portolés T. Chromatography hyphenated to high resolution mass spectrometry in untargeted metabolomics for investigation of food (bio)markers. TrAC Trends Anal Chem. 2021; 135: 116161.
  • (3) Gómez-Zorita S, González-Arceo M, Trepiana J, Aguirre L, Crujeiras AB, Irles E, et al. Comparative effects of pterostilbene and its parent compound resveratrol on oxidative stress and inflammation in steatohepatitis induced by high-fat highfructose feeding. Antioxidants. 2020; 9: 1042.
  • (4) Gimeno-Mallench L, Mas-Bargues C, Inglés M, Olaso G, Borras C, Gambini J, Vina J. Resveratrol shifts energy metabolism to increase lipid oxidation in healthy old mice. Biomed Pharmacother. 2019; 118: 109130.
  • (5) Mazur-Bialy AI, Pochec E, Plytycz B. Immunomodulatory effect of riboflavin deficiency and enrichment—Reversible pathological response versus silencing of inflammatory activation. J Physiol Pharmacol. 2015; 66: 793-802.
  • (6) Asghari S, Hamedi-Shahraki S, Amirkhizi F. Systemic redox imbalance in patients with nonalcoholic fatty liver disease. Eur J Clin Invest. 2020; 50(4): e13211.